Episode 11: Are we All Part of the GLP-1 Experiment?
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Episode 11: Are we All Part of the GLP-1 Experiment?
-
Narrated by:
-
By:
About this listen
GLP-1 drugs like Ozempic and Wegovy have transformed conversations around weight loss and metabolic health — but are we witnessing a medical breakthrough or participating in a massive social experiment?
In this episode, we explore how these FDA-approved drugs moved from diabetes treatment to mainstream use for weight management, reshaping medicine, ethics, and culture along the way. We discuss how science identifies new uses for existing drugs, what we’ve learned from past off-label revolutions, and why GLP-1s may be testing not just our metabolism, but our trust in modern medicine itself.
Topics include:
- How GLP-1 receptor agonists work in the brain and body
- Why appetite, reward, and dopamine matter
- The balance between scientific discovery and real-world experimentation
- What this moment reveals about how we use (and market) medicine today
Available on all streaming platforms — just search “Gopu & Zane” or visit lybrandlab.org/jospod
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.